Extracoporeal photochemotherapy in cutaneous lupus erythematosus

Journal of the European Academy of Dermatology and Venereology

Volumn 13, Issue 2, 1999, Pages 127-130

  Wollina, U ^a   Looks, A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Cutaneous lupus erythematosus; Extracoporeal photochemotherapy; Side effects

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; METHOXSALEN; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SKIN LUPUS ERYTHEMATOSUS; DISCOID LUPUS ERYTHEMATOSUS; FOLLOW UP; PUVA; TREATMENT OUTCOME;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; METHOXSALEN; PREDNISOLONE; PUVA THERAPY; TREATMENT OUTCOME;

EID: 0032589590     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0926-9959(99)00078-1     Document Type: Article

References (21)

1. Wollina U, Schaarschmidt H, Knopf B, Hipler C. Modulation of antibody binding to double-stranded (ds) DNA and Ro/SSA antigens by UV-irradiation of human epidermis in vitro. Studia Biophys 1988;124:251-258.
2. Lehmann P, Hölzle E, Kind P, Goerz G, Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UV-A and UV-B-radiation. J Am Acad Dermatol 1990;22:181-187.
3. Hasan T, Nyberg F, Stephansson E, Puska P, Häkkinen M, Sarna S, et al. Photosensitivity in lupus erythematosus. UV photoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol 1997;136:699-705.
4. Neumann C. Induktion eines subakuten kutanen Lupus erythematodes durch psorale UV-A-Therapie. Z Hautkrankh 1987;62:1523-1528.
5. Klein LR, Elmets CA, Callen JP. Photoexacerbation of cutaneous lupus erythematosus due to ultraviolet A light emission from a photocopier. Arthritis Rheum 1995;38:1152-1156.
6. Wollina U. Relapsed hypertrophic lupus erythematosus after etretinat withdrawal - treatment by cutaneous surgery. Dermatol Monatsschr 1993;179:205-208.
7. Morison WL. In vivo effects of psoralen plus longwave ultraviolet radiation on immunity. Natl Cancer Inst Monogr 1984;66:243-246.
8. Sönnichsen N, Meffert H, Kunzelmann V, Audring H. UV-A-1-Therapie bei subakut-kutanem Lupus erythematodes. Hautarzt 1993;44:723-725.
9. Molina JF, McGrath Jr H. Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus. J Rheumatol 1997;24:1072-1074.
10. Knobler RM, Graninger W, Lindmaier A, Trautinger F, Smolen J. Extracorporeal photochemotherapy for the treatment of systemic lupus erythematosus: a pilot study. Arthritis Rheum 1992;35:319-324.
11. Licht-Mbalyohere A, Heller A, Stadler R. Extracorporeal photochemotherapy of therapy-refractory cases of systemic lupus erythematosus with urticarial vasculitis and pemphigus foliaceus. Eur J Dermatol 1996;6:106-109.
12. Edelson RL, Berger CL, Gasparro FP, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987;316:297-303.
13. Le Feber WP, Norris DA, Ryan SS. Ultraviolet light induces expression of selected nuclear antigens on cultured human keratinocytes. J Clin Invest 1984;74:1545-1551.
14. Wollina U, Hipler C, Schaarschmidt H. UVA-Exposition humaner Epidermis ermöglicht die Bindung von Antikörpern gegen SSA/ Ro in vitro. Hautarzt 1988;39:136-138.
15. Furukawa F, Kashihara-Sawami M, Lyons MB, Norris DA. Binding of antibodies to the extractable nuclear antigens SSA/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 1990;94:77-85.
16. Kuhn A, Fehsel K, Lehmann P, Krutmann J, Ruzicka T, Kolb-Bachofen V. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol 1998;111:149-153.
17. Berger CL, Perez M, Laroche L, Edelson R. Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol 1990;94:52-57.
18. Di Renzo M, Rubegni P, De Aloe G, Paulesu L, Pasqui AL, Andreassi L, et al. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma. Immunology 1997;92:99-103.
19. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998;41:838-844.
20. Funauchi M, Ikoma S, Enomoto H, Horiuchi A. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998;27:219-224.
21. Viallard JF, Pellegrin JL, Ranchin V, Schaeverbeke T, Dehais J, Longy-Boursier M, et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SCLE). Clin Exp Immunol 1999;115:189-195.